Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy
- 1 March 1996
- journal article
- case report
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 27 (3) , 431-434
- https://doi.org/10.1016/s0272-6386(96)90369-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Foscarnet-induced hypokalaemiaJournal of Infection, 1992
- FoscarnetDrugs, 1991
- Nephrogenic Diabetes Insipidus Associated with Foscarnet Treatment of Cytomegalovirus RetinitisAnnals of Internal Medicine, 1990
- Foscarnet Nephrotoxicity: Mechanism, Incidence and PreventionAmerican Journal of Nephrology, 1989
- The Use of the Urinary Anion Gap in the Diagnosis of Hyperchloremic Metabolic AcidosisNew England Journal of Medicine, 1988
- Treatment of Cytomegalovirus Retinitis with Trisodium Phosphonoformate Hexahydrate (Foscarnet)The Journal of Infectious Diseases, 1988
- Differential Diagnosis of PolyuriaAnnual Review of Medicine, 1988
- Inhibition of human renal epithelial Na+/Pi cotransport by phosphonoformic acidBiochemical and Biophysical Research Communications, 1986
- Arterial Pco2 in chronic metabolic acidosisKidney International, 1982
- The Critical Importance of Urinary Concentrating Ability in the Generation of Urinary Carbon Dioxide TensionJournal of Clinical Investigation, 1977